CLINICAL CENTER OF SERBIA - Serbia 

Ranking results:

Past rankings:

2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 5.999.860 0 1
2010 0 5.999.436 145.103 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ARTTIC1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
FONDATION HOPITAL SAINT JOSEPH1
INSTITUTE FOR INFECTIOUS DISEASES PROF DR MATEI BALS1
JULIUSMAXIMILIANS UNIVERSITAET WUERZBURG1
STICHTING KATHOLIEKE UNIVERSITEIT1
STICHTING NIJMEEGS INTERCONFESSIONEEL ZIEKENHUIS CANISIUS WILHELMINA1
THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITE DE GENEVE1
UNIVERSITEIT ANTWERPEN1
UNIVERSYTET MEDYCZNY W LODZI1

Constancy:

Total number of partners: 15
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 15
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2011-12-01Preserving old antibiotics for the future : assessment of clinical efficacy by a pharmacokinetic/pharmacodynamic approach to optimize effectiveness and reduce resistance for off-patent antibiotics AIDAparticipant5.999.86019
2010-01-01Impact of Specific Antibiotic Therapies on the prevalence of hUman host ResistaNt bacteria SATURNparticipant5.999.43616

Alias institution names:

  • CLINICAL CENTER OF SERBIA
  • KLINICKI CENTAR SRBIJE